VT STRONG NEWS – Burlington, VT: DOJ Vermont reports –

The U.S. Attorney’s Office has developed and launched a drug prevention initiative.  Speaking today at Turning Point, located at 179 North Winooski Avenue, Burlington, Vermont, U.S. Attorney Christina E. Nolan described the initiative and played the accompanying Public Service Announcement (PSA) and documentary film, Face of Recovery.  Both the PSA and documentary focus on the story of Justin Goulet, who has a history of addiction to drugs and was previously convicted of federal drug and gun crimes.  Mr. Goulet made a remarkable recovery and has enjoyed an extended period of sobriety. 

The U.S. Attorney’s Office worked with Film Production Director, Jeremy Leibovitch, and Graham Raubvogel, both of Prom Creative, to create the PSA and documentary. This drug prevention initiative is an outreach project that carries a message of hope in the midst of the drug crisis.  The documentary and PSA are also meant to highlight the existence and importance of solidarity and collaboration amongst Vermont’s enforcement, prevention, treatment, and recovery communities.  The U.S. Attorney’s Office plans to present Face of Recovery to audiences across the Vermont, including to young people and at community and recovery centers.  The presentations will be interactive, with attendance by Mr. Goulet and U.S. Attorney Nolan, as well as time for conversation and questions and answers.  The first public viewing and interactive presentation will occur on July 19 at Turning Point, 179 North Winooski Avenue, Burlington, Vermont.

This prevention initiative has been a collective effort.  The U.S. Attorney’s Office thanks Mr. Goulet, Mr. Leibovitch, Mr. Raubvogel, and Turning Point for their essential contributions to the Project. 

If you are interested in scheduling a presentation and showing, please contact Aimee Stearns, Victim Witness Coordinator, or Kraig LaPorte, Public Information Officer, at the U.S. Attorney’s Office at (802) 951-6725.

The Face of Recovery documentary film and PSA